HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Campwala, S. Z. Articles by Pai, R. G. Search for Related Content PubMed Articles by Campwala, S. Z. Articles by Pai, R. G. Related Collections Coronary disease Valve disease

Eur J Cardiothorac Surg 2005;28:778-779
© 2005 Elsevier Science NL

Letter to the Editor

Reply to Raja

Divisions of Cardiology, Loma Linda University Medical Center, Loma Linda, CA, USA

Received 3 August 2005; accepted 5 August 2005.

^_* Corresponding author. Division of Cardiology, University of Southern California, 1510 San Pablo Street, 322, Los Angeles, CA 90033, USA. Tel.: +1 323 442 6131; fax: +1 323 442 6133. (Email: rpai@usc.edu).

Key Words: Coronary artery bypass surgery • Mitral regurgitation • Coronary artery disease

The first 20% of the full text of this article appears below.

We want to thank Dr Raja for his interest in our paper [1]. The main message of our paper is that 3 or 4 + MR regression in the setting of ischemic cardiomyopathy depends upon LV size reduction following CABG. This depends on presence of adequate viable myocardium . . . [Full Text of this Article]